1. Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors

    Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors

    NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Karen is a world class cancer researcher and a highly accomplished leader in her field.
    2. Karen brings to the Board deep scientific expertise developed through a successful career in research, including her current leadership role at one of the world's most influential cancer research organizations.
    3. Bristol-Myers Squibb has been at the forefront of researching and developing new therapies that harness the immune system to fight cancer.
  3. Topics Mentioned